EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The United States’ Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research

Daniel Eisenman

Applied Biosafety · 2019-09 · 24 (3) · 147-152

DOI: 10.1177/1535676019854866 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Applied Biosafety, online erschienen am 18.06.2019. Verfasst von Daniel Eisenman. Beteiligte Einrichtung: Advarra, Research Triangle Park, NC, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A dramatic increase in the number of clinical trials involving gene-modified cell therapy and gene therapy is taking place. The field is on the verge of a boom, and the regulatory environment is evolving to accommodate the growth.

Discussion

This commentary summarizes the current state of the field, including an overview of the growth. The United States (US) regulatory structure for gene therapy will be summarized, and the evolution of the oversight structure will be explained.

Conclusion

The gene therapy field has recently produced its first FDA-approved therapeutics and has a pipeline of other investigational products in the final stages of clinical trials before they can be evaluated by the FDA as safe and effective therapeutics. As research continues to evolve, so must the oversight structure. Biosafety professionals and IBCs have always played key roles in contributing to the safe, evidence-based advancement of gene therapy research. With the recent regulatory changes and current surge in gene therapy research, the importance of those roles has increased dramatically.

Schlagwörter

Stichwörter der Autor:innen

NIH guidelinesRMAT designationgene therapyinvestigational new drug (IND)recombinant DNA advisory committee (RAC)

Autor:innen und Institutionen

  • Advarra, Research Triangle Park, NC, USA.

Zitieren

APA

Eisenman, D. (2019). The United States’ Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research. Applied Biosafety, 24(3), 147-152. https://doi.org/10.1177/1535676019854866

Vancouver

Eisenman D. The United States’ Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research. Applied Biosafety. 2019;24(3):147-152. doi:10.1177/1535676019854866

BibTeX
@article{Eisenman2019,
  author = {Eisenman, Daniel},
  title = {The United States’ Regulatory Environment Is Evolving to Accommodate a Coming Boom in Gene Therapy Research},
  journal = {Applied Biosafety},
  year = {2019},
  volume = {24},
  number = {3},
  pages = {147--152},
  doi = {10.1177/1535676019854866}
}
Kostenlos starten →